Extended NIPT in London

Extended NIPT is a highly advanced form of non-invasive prenatal testing that screens for a comprehensive range of chromosomal abnormalities and genetic conditions during pregnancy. Unlike standard NIPT which focuses on the three most common trisomies, extended NIPT analyses additional chromosomes, sex chromosome disorders, rare trisomies, and microdeletions that could affect fetal development. The test uses sophisticated laboratory techniques to analyse cell-free fetal DNA circulating in maternal blood, providing detailed genetic information about your baby from as early as 9 weeks of pregnancy without any risk to mother or child.

Extended NIPT is particularly beneficial for expectant parents seeking comprehensive genetic screening, those with family history of chromosomal disorders, or mothers of advanced maternal age where chromosome abnormalities become more common. The test can detect conditions ranging from Down syndrome and Edwards syndrome to rarer microdeletions like DiGeorge syndrome, providing peace of mind and enabling informed decision-making about pregnancy management. Our fetal medicine specialists at London Pregnancy Clinic combine extended NIPT with expert ultrasound assessment and genetic counselling to provide the most thorough prenatal screening available in the UK.

Extended NIPT achieves detection rates of over 99% for major chromosomal conditions. These include Down syndrome, Edwards syndrome, and Patau syndrome. False positive rates are typically below 0.1%. For sex chromosome abnormalities and microdeletions, detection rates vary depending on the specific condition but generally range from 80-95%. The high accuracy stems from advanced laboratory techniques that analyse millions of DNA fragments and sophisticated algorithms that can distinguish between maternal and fetal genetic material with exceptional precision.

However, it’s important to understand that NIPT is a screening test, not a diagnostic test, meaning it indicates probability rather than definitive diagnosis. Positive results require confirmation through diagnostic procedures such as amniocentesis or chorionic villus sampling. Our genetic counsellors explain that whilst extended NIPT significantly reduces the need for invasive testing, it cannot detect all possible genetic conditions, structural abnormalities visible on ultrasound, or neural tube defects. The accuracy of extended NIPT may be affected by factors including maternal weight, multiple pregnancy, or placental mosaicism. Our fetal medicine team provides detailed counselling about test limitations and discusses appropriate follow-up based on individual risk factors and screening results.

Extended NIPT is recommended for all pregnancies where comprehensive genetic screening is desired, particularly for women of advanced maternal age (typically over 35), those with family history of chromosomal abnormalities, or couples who have previously had a pregnancy affected by genetic conditions. The test is also valuable when standard screening tests indicate increased risk, when detailed ultrasound scanning identifies potential fetal abnormalities, or for mothers who prefer non-invasive screening over diagnostic procedures with associated miscarriage risk.

Extended NIPT is especially beneficial for multiple pregnancies where standard screening may be less accurate, pregnancies conceived through IVF where genetic screening provides additional reassurance, or when parents specifically wish to screen for conditions beyond the standard trisomies. Our fetal medicine specialists also recommend extended NIPT for mothers with anxiety about genetic conditions, enabling early reassurance and informed decision-making throughout pregnancy. However, extended NIPT may not be suitable in certain circumstances including very early pregnancy before 9 weeks, previous history of genetic mosaicism, or certain maternal medical conditions. Our genetic counsellors provide personalised recommendations based on individual medical history, family background, and pregnancy-specific factors during pre-test counselling consultations.

A positive extended NIPT result indicates an increased probability that your baby may have the specific genetic condition identified, but this requires confirmation through diagnostic testing such as amniocentesis. Our fetal medicine team provides immediate support and detailed genetic counselling to explain the implications of positive results, discuss the accuracy of the specific finding, and outline next steps including diagnostic options and specialist referrals where appropriate.

Following positive extended NIPT results, we arrange urgent specialist consultations with our consultant geneticists and fetal medicine specialists who provide comprehensive counselling about the detected condition, its potential impact on the baby’s health and development, and available management options. This includes detailed ultrasound assessment to look for associated structural abnormalities, discussion of diagnostic testing procedures, and connection with specialist support services. Our team ensures you receive accurate, balanced information to support informed decision-making, whilst providing emotional support throughout this challenging time. We work closely with NHS fetal medicine units and specialist paediatric services to ensure seamless care coordination and appropriate ongoing monitoring throughout pregnancy.

Extended NIPT platforms available at London Pregnancy Clinic include Panorama AI NIPT, KNOVA NIPT, PrenatalSafe, and Illumina options, each offering different screening capabilities and detection panels. Panorama AI incorporates artificial intelligence algorithms for enhanced accuracy and can analyse fetal fraction to optimise results reliability. KNOVA NIPT provides one of the most comprehensive screening panels available, detecting over 30 genetic conditions including rare microdeletions and single gene disorders.

PrenatalSafe offers flexible screening options with different panel sizes depending on individual requirements and risk factors, whilst Illumina platforms provide robust, well-validated screening for standard and extended conditions. The choice of platform depends on specific screening requirements, individual risk factors, and clinical recommendations from our fetal medicine specialists. All platforms use advanced sequencing technology and sophisticated bioinformatics analysis to achieve maximum accuracy. Our genetic counsellors explain the differences between available options and help select the most appropriate extended NIPT platform based on your individual circumstances, family history, and screening preferences during pre-test consultations.

Extended NIPT and diagnostic testing such as amniocentesis serve different purposes in prenatal care and are often complementary rather than alternatives. Extended NIPT is a screening test that indicates probability of genetic conditions with very high accuracy but cannot provide definitive diagnosis. It is completely safe with no miscarriage risk, can be performed from 9 weeks, and screens for multiple conditions simultaneously.

Diagnostic testing through amniocentesis provides definitive genetic diagnosis but carries a small miscarriage risk (approximately 1 in 200-500 according to recent studies) and is typically performed after 15 weeks of pregnancy. Amniocentesis can detect all chromosomal abnormalities and genetic conditions that can be identified through genetic testing, making it more comprehensive than even extended NIPT. Many couples choose extended NIPT first due to its safety profile, using diagnostic testing only if screening results indicate increased risk. Our fetal medicine specialists discuss both options during genetic counselling, explaining how they complement each other and helping you make informed decisions about prenatal genetic assessment based on individual risk factors and personal preferences.